Prairie Cancer Consortium leadership and members share updates with the Network
On Thursday, September 26th, leadership and researchers from the Prairie Cancer Consortium (PR2C) presented their work to Network members as part of the MOHCCN seminar series.
This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network.
This event was co-chaired by Debbie Duclos, a registered nurse and member of the MOHCCN Patient Working Group from Campbellville, ON, and Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.
Watch the full video
Speakers
PR2C CONSORTIUM ACTIVITIES UPDATE
Dr. Jennifer Chan - Associate Professor, Cumming School of Medicine, Department of Pathology and Laboratory Medicine, University of Calgary; Director, Arnie Charbonneau Cancer Institute; MOHCCN consortium lead (PR2C)
RESEARCH PRESENTATIONS
Precision Choice at the Point of Care
Dr. Laura Hopkins - Professor, Department of Oncology, College of Medicine, University of Saskatchewan; Gynecologic oncologist, Saskatchewan Cancer Agency; MOHCCN cohort lead
Predicting response to immune checkpoint blockades in sarcoma
Dr. Hyojin Song - Postdoctoral associate, Morrissy lab, Cumming School of Medicine, University of Calgary
Related Team Members
-
Sorana
Research LeadProject LeaderWorking Group Member
Morrissy -
Jennifer
MOHCCN Steering CommitteeConsortium LeaderProject LeaderWorking Group MemberResearcher
Chan -
Laura
ResearcherProject Leader
Hopkins
Projects
-
Regional Consortia
Prairie Cancer Consortium
- Alberta
- Manitoba
- Saskatchewan
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
Related News
-
Precision medicine should be first-line treatment for metastatic pancreatic cancer, study finds
A new clinical trial comparing the efficacy of two treatments commonly used on patients with metastatic pancreatic cancer has shed new light on the importance of using genomic sequencing to inform car... -
Atlantic Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
Prairie Cancer Consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
Marathon of Hope – Québec consortium leadership and members share updates with the Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing...